載入...
Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
INTRODUCTION: The safety and efficacy of exenatide once weekly (EQW) is overall well established. EQW is primarily renally eliminated. In this study, the efficacy and renal and gastrointestinal tolerability of EQW were summarised in participants with type 2 diabetes and chronic kidney disease stage...
Na minha lista:
| 發表在: | Diabetes Ther |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7324446/ https://ncbi.nlm.nih.gov/pubmed/32306296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00815-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|